Please use this identifier to cite or link to this item: https://hdl.handle.net/11147/9678
Title: Therapeutic Potentials of Inhibition of Jumonji C Domain-containing Demethylases in Acute Myeloid Leukemia
Authors: Koca, Duygu
Hastar, Nurcan
Engür, Selin
Kiraz, Yağmur
Ulu, Gizem Tuğçe
Çekdemir, Demet
Baran, Yusuf
Koca, Duygu
Hastar, Nurcan
Kiraz, Yağmur
Ulu, Gizem Tuğçe
Baran, Yusuf
Izmir Institute of Technology. Molecular Biology and Genetics
Moleküler Biyoloji ve Genetik Bölümü
Moleküler Biyoloji ve Genetik Bölümü
Anadolu Üniversitesi
Moleküler Biyoloji ve Genetik Bölümü
Moleküler Biyoloji ve Genetik Bölümü
Sakarya Üniversitesi
Moleküler Biyoloji ve Genetik Bölümü
Keywords: Acute myeloid leukemia
Methylstat
Jumonji C domain
Histone methylation
Issue Date: 2020
Publisher: Aves
Abstract: Acute myeloid leukemia (AML) is a complex disease affected by both genetic and epigenetic factors. Histone methylation and demethylation are types of epigenetic modification in chromatin remodeling and gene expression. Abnormal expression of histone demethylases is indicated in many types of cancer including AML. Although many commercial drugs are available to treat AML, an absolute cure has not been discovered yet. However, inhibition of demethylases could be a potential cure for AML. Methylstat is a chemical agent that inhibits the Jumonji C domain-containing demethylases.
URI: https://hdl.handle.net/11147/9678
ISSN: 13007777
13085263
Appears in Collections:Molecular Biology and Genetics / Moleküler Biyoloji ve Genetik
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Files in This Item:
File Description SizeFormat 
baran.pdfTam Metin / Full Text656.27 kBAdobe PDFThumbnail
View/Open
Show full item record

CORE Recommender

Page view(s)

40
checked on Sep 21, 2021

Download(s)

18
checked on Sep 21, 2021

Google ScholarTM

Check

Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.